DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
Mounjaro and Zepbound are the same molecule — tirzepatide — on the same weekly schedule: 2.5 mg up to 15 mg, one step every 4 weeks. Here is every dose, what each step is for, and why it always starts at a dose that barely works.
| When | Dose (weekly) | What it is |
|---|---|---|
| Weeks 1–4 | 2.5 mg | Starting / tolerance dose (not a treatment dose) |
| Weeks 5–8 | 5 mg | First maintenance option |
| Weeks 9–12 | 7.5 mg | Titration step |
| Weeks 13–16 | 10 mg | Second maintenance option |
| Weeks 17–20 | 12.5 mg | Titration step |
| Week 21+ | 15 mg | Top dose (max average loss in SURMOUNT-1) |
Each step is held ~4 weeks before increasing. Many people stop at 5 or 10 mg if it works — 15 mg is the top dose, not a required destination.
The 2.5 mg starting dose is sub-therapeutic by design — too low to drive much weight loss, chosen only to build tolerance and blunt the nausea, vomiting, and diarrhea a higher start would cause. That is why the first month feels underwhelming: you are on a tolerance dose, not the treatment dose. See the week-by-week experience in the Zepbound timeline.
Mounjaro (type 2 diabetes) and Zepbound(weight loss) are the identical molecule on the identical 2.5→15 mg titration — the difference is the on-label indication, not the dose ladder. For semaglutide’s schedule instead, see the semaglutide dosage chart; to understand why tirzepatide (a dual GIP/GLP-1 agonist) tends to out-lose semaglutide, read what is a GLP-1.
Within 4 days (96 hours) of the missed weekly dose, take it. Past 4 days, skip it and resume on your normal day — never double up. Miss several weeks and your prescriber may re-titrate you from a lower dose. When unsure, ask.